Detalhe da pesquisa
1.
Structure-based design of low-nanomolar PIM kinase inhibitors.
Bioorg Med Chem Lett
; 25(3): 474-80, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575657
2.
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1.
Bioorg Med Chem Lett
; 22(5): 2070-4, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22326168
3.
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors.
Bioorg Med Chem Lett
; 22(12): 4033-7, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22607669
4.
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Bioorg Med Chem Lett
; 21(18): 5633-7, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21798738
5.
7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors.
J Med Chem
; 49(17): 5352-62, 2006 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-16913725
6.
Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
J Med Chem
; 47(15): 3865-73, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15239664
7.
Stereoselective synthesis of the C1-C13 fragment of 2,3-dihydrodorrigocin A.
J Org Chem
; 70(20): 8212-5, 2005 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16277352